4.6 Review

Randomised clinical trials in critical care: past, present and future

Related references

Note: Only part of the references are listed.
Article Anesthesiology

Lower versus higher oxygenation targets in critically ill patients with severe hypoxaemia: secondary Bayesian analysis to explore heterogeneous treatment effects in the Handling Oxygenation Targets in the Intensive Care Unit (HOT-ICU) trial

Thomas L. Klitgaard et al.

Summary: In the HOT-ICU trial, a lower oxygenation target did not affect overall mortality among critically ill adult patients, but may increase mortality risk for patients with higher baseline norepinephrine doses. These findings suggest a dose-response relationship between baseline norepinephrine dose and the impact of oxygenation target on mortality.

BRITISH JOURNAL OF ANAESTHESIA (2022)

Article Critical Care Medicine

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

Anders Granholm et al.

Summary: The study showed that in patients with COVID-19 and severe hypoxaemia, daily use of dexamethasone 12 mg compared to 6 mg had high probabilities of benefit and low probabilities of clinically important harm in all outcomes up to 90 days.

INTENSIVE CARE MEDICINE (2022)

Editorial Material Obstetrics & Gynecology

Multiple comparisons: a tutorial. Part 1. Understanding hypothesis testing

Michael T. Lawson et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)

Article Critical Care Medicine

Using Bayesian Methods to Augment the Interpretation of Critical Care Trials An Overview of Theory and Example Reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial

Fernando G. Zampieri et al.

Summary: Most randomized trials are traditionally analyzed using frequentist statistical approaches like null hypothesis testing and P values. However, the concept of P values can be difficult to understand and may lead to misinterpretation. Bayesian methods offer an alternative probabilistic interpretation of data, providing a distribution of effect sizes compatible with observed trial data based on prior assumptions. Bayesian reanalysis, although increasingly common, raises concerns about potential bias if priors are not predefined. Standardization of priors in Bayesian reanalysis of clinical trials may be beneficial for the critical care community.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Article Medicine, General & Internal

Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure

Olav L. Schjorring et al.

Summary: Among adult patients with acute hypoxemic respiratory failure in the ICU, setting a lower target for arterial oxygen did not result in lower mortality at 90 days compared to a higher target.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia The COVID STEROID 2 Randomized Trial

Marie W. Munch et al.

Summary: In patients with COVID-19 and severe hypoxemia, the use of 12 mg/d of dexamethasone compared to 6 mg/d did not lead to a statistically significant difference in the number of days alive without life support at 28 days. The study may have lacked the power to detect a significant effect.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Critical Care Medicine

Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial

Yahya Shehabi et al.

Summary: The study aimed to quantify potential heterogeneity of treatment effect (HTE) of early sedation with dexmedetomidine (DEX) compared with usual care. Results showed that DEX was associated with lower 90-day mortality in patients over 65 years old, while younger patients may experience increased mortality with DEX. Further research is needed to confirm these findings.

INTENSIVE CARE MEDICINE (2021)

Article Medicine, General & Internal

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Anthony C. Gordon et al.

Summary: Interleukin-6 receptor antagonists tocilizumab and sarilumab were found to improve outcomes, including survival, in critically ill patients with Covid-19 receiving organ support in ICUs according to an ongoing international trial. The efficacy of these treatments has been confirmed, with patients benefiting from the therapy.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Medicine, General & Internal

Platform Trials - Beware the Noncomparable Control Group

Lori E. Dodd et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Anesthesiology

Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial

Marie Warrer Munch et al.

Summary: The study aimed to assess the effects of low-dose hydrocortisone on patients with severe hypoxia due to COVID-19, but was terminated early with only 3% of the planned sample size enrolled, leading to imprecise estimates of benefits and harms.

ACTA ANAESTHESIOLOGICA SCANDINAVICA (2021)

Review Anesthesiology

Patient-important outcomes other than mortality in recent ICU trials: Protocol for a scoping review

Anders Granholm et al.

Summary: This scoping review aims to provide an overview of choices, definitions, and handling of patient-important outcomes other than mortality in contemporary RCTs conducted in adult ICU patients, which may guide discussions with patients and relatives, the design of future RCTs, and research on optimal outcome choices and handling.

ACTA ANAESTHESIOLOGICA SCANDINAVICA (2021)

Article Critical Care Medicine

Clinical Research: From Case Reports to International Multicenter Clinical Trials

Simon Finfer et al.

Summary: Extra digital content is available in the text.

CRITICAL CARE MEDICINE (2021)

Article Medicine, General & Internal

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis

Manu Shankar-Hari et al.

Summary: This study identified 27 clinical trials and found that the use of IL-6 antagonists was associated with lower 28-day all-cause mortality in patients hospitalized for COVID-19 compared to usual care or placebo. Different risk effects were observed between tocilizumab and sarilumab, increasing understanding of the treatment with these drugs.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Editorial Material Health Care Sciences & Services

Shifting the focus away from binary thinking of statistical significance and towards education for key stakeholders: revisiting the debate on whether it's time to de-emphasize or get rid of statistical significance

Guowei Li et al.

Summary: The article revisits the controversy surrounding the use of P-values and statistical significance in clinical research, emphasizing the importance of educating key stakeholders.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Surgery

To test or to estimate? P-values versus effect sizes

Daniela Dunkler et al.

TRANSPLANT INTERNATIONAL (2020)

Article Medicine, General & Internal

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration

David M. Kent et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Critical Care Medicine

Is Mortality a Useful Primary End Point for Critical Care Trials?

Richard A. Veldhoen et al.

CHEST (2020)

Article Medicine, Research & Experimental

Comparison of methods for control allocation in multiple arm studies using response adaptive randomization

Kert Viele et al.

CLINICAL TRIALS (2020)

Article Medicine, General & Internal

Conservative Oxygen Therapy during Mechanical Ventilation in the ICU

Diane Mackle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Health Care Sciences & Services

Comparison of Bayesian and frequentist group-sequential clinical trial designs

Nigel Stallard et al.

BMC MEDICAL RESEARCH METHODOLOGY (2020)

Editorial Material Medicine, General & Internal

When Should Clinicians Act on Non-Statistically Significant Results From Clinical Trials?

Paul J. Young et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Medicine, General & Internal

Optimizing the Trade-off Between Learning and Doing in a Pandemic

Derek C. Angus

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Health Care Sciences & Services

An overview of platform trials with a checklist for clinical readers

Jay J. H. Park et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)

Article Health Care Sciences & Services

Do we need to adjust for interim analyses in a Bayesian adaptive trial design?

Elizabeth G. Ryan et al.

BMC MEDICAL RESEARCH METHODOLOGY (2020)

Article Critical Care Medicine

Powering Bias and Clinically Important Treatment Effects in Randomized Trials of Critical Illness*

Darryl Abrams et al.

CRITICAL CARE MEDICINE (2020)

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Critical Care Medicine

Paying the Piper: The Downstream Implications of Manipulating Sample Size Assumptions for Critical Care Randomized Control Trials

Brian H. Cuthbertson et al.

CRITICAL CARE MEDICINE (2020)

Editorial Material Multidisciplinary Sciences

Retire statistical significance

Valentin Amrhein et al.

NATURE (2019)

Article Critical Care Medicine

Reappraisal of Ventilator-Free Days in Critical Care Research

Nadir Yehya et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Health Care Sciences & Services

Using Bayesian adaptive designs to improve phase III trials: a respiratory care example

Elizabeth G. Ryan et al.

BMC MEDICAL RESEARCH METHODOLOGY (2019)

Article Medicine, General & Internal

Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis

Christopher W. Seymour et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Review Health Care Sciences & Services

Overall bias and sample sizes were unchanged in ICU trials over time: a meta-epidemiological study

Carl Thomas Anthon et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)

Article Medicine, Research & Experimental

Mind the gap? The platform trial as a working environment

Liz Morrell et al.

TRIALS (2019)

Editorial Material Anesthesiology

Use of the GRADE approach in systematic reviews and guidelines

Anders Granholm et al.

BRITISH JOURNAL OF ANAESTHESIA (2019)

Editorial Material Critical Care Medicine

Intensive care medicine rapid practice guidelines (ICM-RPG): paving the road of the future

Waleed Alhazzani et al.

INTENSIVE CARE MEDICINE (2019)

Article Biotechnology & Applied Microbiology

Adaptive platform trials: definition, design, conduct and reporting considerations The Adaptive Platform Trials Coalition

Derek C. Angus et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Medicine, General & Internal

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial

Pierre-Francois Laterre et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Editorial Material Critical Care Medicine

Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls

C. H. van Werkhoven et al.

INTENSIVE CARE MEDICINE (2019)

Review Medicine, General & Internal

Higher versus lower fraction of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit

Marija Barbateskovic et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)

Article Medicine, General & Internal

Adaptive designs in clinical trials: why use them, and how to run and report them

Philip Pallmann et al.

BMC MEDICINE (2018)

Article Critical Care Medicine

Ventilator-Free Day Outcomes Can Be Misleading

Laetitia Bodet-Contentin et al.

CRITICAL CARE MEDICINE (2018)

Article Medicine, General & Internal

Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome

A. Combes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Immunology

Arguing for Adaptive Clinical Trials in Sepsis

Victor B. Talisa et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Medicine, General & Internal

Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU

M. Krag et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Editorial Material Medicine, General & Internal

The Utility in Composite Outcome Measures Measuring What Is Important to Patients

Telba Z. Irony

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Medicine, General & Internal

Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis

Kathryn M. Rowan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Critical Care Medicine

Patient-important outcomes in randomized controlled trials in critically ill patients: a systematic review

Stephane Gaudry et al.

ANNALS OF INTENSIVE CARE (2017)

Article Medicine, Research & Experimental

A simulation study of outcome adaptive randomization in multi-arm clinical trials

J. Kyle Wathen et al.

CLINICAL TRIALS (2017)

Article Critical Care Medicine

Effect sizes in ongoing randomized controlled critical care trials

Elliott E. Ridgeon et al.

CRITICAL CARE (2017)

Article Medicine, Research & Experimental

Efficiencies of platform clinical trials: A vision of the future

Benjamin R. Saville et al.

CLINICAL TRIALS (2016)

Article Public, Environmental & Occupational Health

Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations

Sander Greenland et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2016)

Review Medicine, General & Internal

Pragmatic Trials

Ian Ford et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Anesthesiology

Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries

M. Krag et al.

ACTA ANAESTHESIOLOGICA SCANDINAVICA (2015)

Article Critical Care Medicine

Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care

Theodore J. Iwashyna et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Review Critical Care Medicine

Progress on core outcome sets for critical care research

Bronagh Blackwood et al.

CURRENT OPINION IN CRITICAL CARE (2015)

Editorial Material Medicine, General & Internal

The Platform Trial An Efficient Strategy for Evaluating Multiple Treatments

Scott M. Berry et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Critical Care Medicine

Outcomes and Statistical Power in Adult Critical Care Randomized Trials

Michael O. Harhay et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

Review Critical Care Medicine

Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients

Mette Krag et al.

INTENSIVE CARE MEDICINE (2014)

Article Medicine, General & Internal

Albumin Replacement in Patients with Severe Sepsis or Septic Shock

Pietro Caironi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Anesthesiology

Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review

M. Krag et al.

ACTA ANAESTHESIOLOGICA SCANDINAVICA (2013)

Article Mathematical & Computational Biology

Adaptive enrichment designs for clinical trials

Noah Simon et al.

BIOSTATISTICS (2013)

Article Health Care Sciences & Services

GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength

Jeffrey C. Andrews et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)

Article Health Care Sciences & Services

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations

Jeff Andrews et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)

Article Critical Care Medicine

The added value of ordinal analysis in clinical trials: an example in traumatic brain injury

Bob Roozenbeek et al.

CRITICAL CARE (2011)

Review Critical Care Medicine

Prospective meta-analysis using individual patient data in intensive care medicine

Michael C. Reade et al.

INTENSIVE CARE MEDICINE (2010)

Article Medicine, General & Internal

Statistics notes - The cost of dichotomising continuous variables

DG Altman et al.

BRITISH MEDICAL JOURNAL (2006)

Article Health Care Sciences & Services

Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study

L Sung et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)

Article Medicine, General & Internal

Sifting the evidence - what's wrong with significance tests?

JAC Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2001)